Biofrontera Inc.
BFRI
$0.82
$0.011.12%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -22.61% | 5.15% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -22.61% | 5.15% | |||
| Cost of Revenue | -22.60% | -19.16% | |||
| Gross Profit | -22.62% | 20.08% | |||
| SG&A Expenses | -2.17% | 22.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.97% | 7.42% | |||
| Operating Income | -23.61% | -11.70% | |||
| Income Before Tax | -25.27% | -26.14% | |||
| Income Tax Expenses | -71.43% | 2,200.00% | |||
| Earnings from Continuing Operations | -24.89% | -26.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -24.89% | -26.67% | |||
| EBIT | -23.61% | -11.70% | |||
| EBITDA | -23.83% | -11.84% | |||
| EPS Basic | -8.38% | -20.21% | |||
| Normalized Basic EPS | -8.66% | -19.76% | |||
| EPS Diluted | -8.38% | -20.21% | |||
| Normalized Diluted EPS | -8.66% | -19.76% | |||
| Average Basic Shares Outstanding | 15.24% | 5.38% | |||
| Average Diluted Shares Outstanding | 15.24% | 5.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||